NCT04423952

Brief Summary

The World Health Organization estimates that chronic otitis media could reach between 65 and 350 million people worldwide and thus be an important cause of medical consultation and prescription drugs. The medical care of chronic otitis is difficult, despite several medical and surgical treatment options. Moreover this pathology is gladly recurrent. The completion of a standardized questionnaire to track symptoms objectively over time is fundamental to verify the efficacy of specific treatments and to compare treatments. The quality of life measurement questionnaire related to chronic otitis media (COMQ-12) is a new questionnaire, validated in English, to assist the physician in evaluating chronic otitis media. The objective of this study is to translate and validate the test in French in children.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2020

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
Last Updated

September 25, 2025

Status Verified

October 1, 2024

Enrollment Period

Same day

First QC Date

June 5, 2020

Last Update Submit

September 22, 2025

Conditions

Keywords

Chronic otitis media in childrenStandardized quality of life measurement questionnaire

Outcome Measures

Primary Outcomes (4)

  • Reproducibility

    Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test. COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).

    1 year

  • Consistency reliability test

    Measure of efficiency. Comparison of questionnaires completed by patients and controls. COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).

    1 year

  • Item-total Pearson correlation

    Measure of efficiency. Comparison of questionnaires completed by patients and controls. COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).

    1 year

  • Principal components analysis

    Measure of efficiency. Comparison of questionnaires completed by patients and controls. COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).

    1 year

Study Arms (2)

Patients with chronic otitis media

Patients aged 7 to 15 years with chronic otitis media.

Other: COMQ-12 questionnaire

Controls

Minors aged 7 to 15 years, with no and no history of chronic otitis.

Other: COMQ-12 questionnaire

Interventions

Subjects respond to COMQ-12 questionnaire twice at 15 days apart. COMQ-12 : quality of life measurement questionnaire related to chronic otitis media.

Also known as: Patient questionnaire
ControlsPatients with chronic otitis media

Eligibility Criteria

Age7 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients followed by the department of otolaryngology and cervico-facial surgery of Necker-Enfants Malades hospital and siblings for the control subjects.

You may qualify if:

  • Minors aged 7 to 15 years (inclusive)
  • Patients with chronic otitis media, united or bilateral
  • holders of parental authority not opposed to participation in the study

You may not qualify if:

  • \- Non-comprehension of french

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Necker-Enfants Malades

Paris, 75015, France

Location

MeSH Terms

Interventions

Patient Health Questionnaire

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Françoise Denoyelle, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

May 20, 2020

Primary Completion

May 20, 2020

Study Completion

May 20, 2020

Last Updated

September 25, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations